Vitamin D/VDR in acute kidney injury: a potential therapeutic target.

Vitamin D/VDR in acute kidney injury: a potential therapeutic target.
Curr Med Chem. 2020 Nov 18;:
Authors: Jiang S, Huang L, Zhang W, Zhang H
Abstract
Despite many strategies and parameters used in clinical practice, the incidence and mortality of acute kidney injury (AKI) are still high with poor prognosis. With the development of molecular biology, the role of vitamin D and vitamin D receptor (VDR) in AKI is drawing increasing attention. Accumulated researches have suggested that Vitamin D deficiency is a risk factor of both clinical and experimental AKI, and vitamin D/VDR could be a promising therapeutic target against AKI. However, more qualitative clinical researches are needed to provide stronger evidence for clinical application of vitamin D and VDR agonists in the future. Issues like the route and dosage of administration also await more attention. The present review aims to summarize the current works on the role of vitamin D/VDR in AKI and try to provide some new insight of its therapeutic potential.
PMID: 33213307 [PubMed - as supplied by publisher]

Source: Current Medicinal Chemistry - November 18, 2020 Category: Chemistry Authors: Jiang S, Huang L, Zhang W, Zhang H Tags: Curr Med Chem Source Type: research